Temperature Control During Dialysis Treatment

Sponsor
Regional Hospital Holstebro (Other)
Overall Status
Completed
CT.gov ID
NCT00438295
Collaborator
(none)
18
1
9
2

Study Details

Study Description

Brief Summary

The purpose is to measure the effect of glucose in the dialysis water on blood pressure, pulse rate, and plasma glucose with and without body temperature control

Condition or Disease Intervention/Treatment Phase
  • Procedure: temperature control
Phase 4

Detailed Description

To clarify the influence of temperature in dialysis water on blood pressure and vasoactive hormones

Study Design

Study Type:
Interventional
Actual Enrollment :
18 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effect of Temperature Control During Dialysis Treatment With Glucose in Dialysis Water in Patients With Chronic Renal Failure
Study Start Date :
Aug 1, 2006
Actual Study Completion Date :
May 1, 2007

Outcome Measures

Primary Outcome Measures

  1. Effect of temperature control on blood pressure, pulse rate and blod glucose during dialysis treatment []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Age > 18 years,

  2. both men and women,

  3. chronic renal failure and dialysis treatment for at least three months

Exclusion Criteria:
  1. Heart failure,

  2. Lung insufficiency,

  3. Chronic liver disease,

  4. Diabetes mellitus,

  5. Malignant disease,

  6. Nephrotic syndrome,

  7. Lack of compliance,

  8. Unwillingness til participate

Contacts and Locations

Locations

Site City State Country Postal Code
1 Holstebro Hospital Holstebro Denmark 7500

Sponsors and Collaborators

  • Regional Hospital Holstebro

Investigators

  • Study Chair: Erling B Pedersen, Professor, Regional Hospital Holstebro

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00438295
Other Study ID Numbers:
  • MED.RES.2007.03.EBP
First Posted:
Feb 22, 2007
Last Update Posted:
Sep 15, 2015
Last Verified:
Sep 1, 2007

Study Results

No Results Posted as of Sep 15, 2015